A Strategy Against Antibiotic‐Resistant Bacteria: Optimizing Prevention of Transmission
APMIS · 2026-11 · 134 (11)
DOI: 10.1111/apm.70273 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift APMIS, online erschienen am 09.11.2026. Verfasst von Michael Kemp und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Microbiology, Region Zealand, Zealand University Hospital-Koege, Koege, Denmark. Hauptthemen laut MEDLINE: Cross Infection, Infection Control, Drug Resistance, Bacterial, Gram-Positive Bacterial Infections. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region Zealand, The Vissing Foundation, The A.P. Moller Foundation for the Advancement of Medical Science.
Abstract (Originalsprache)
The rising prevalence of antimicrobial resistance represents a major threat to public health and economic sustainability worldwide. In Europe, vancomycin‐resistant Enterococcus faecium (VREfm) and carbapenemase‐producing Enterobacteriaceae (CPE) are of particular concern, as they cause severe infections that are increasingly difficult or impossible to treat. Transmission of VREfm and CPE occurs predominantly in hospital settings, making prevention of nosocomial spread a central component of resistance control efforts. Effective containment relies on rapid detection of transmission events and early intervention to limit onward spread. This requires intensive laboratory surveillance capable of resolving both clonal transmission and horizontal gene transfer, supported by comprehensive sampling of clinical and environmental isolates. In addition, real‐time sharing of isolate‐level data between hospitals is essential to identify and manage cross‐unit and inter‐institutional transmission. Although such surveillance systems require sustained investment, their costs are modest compared with the substantial clinical and economic burden associated with infections caused by antibiotic‐resistant bacteria. In this mini‐review, we outline a strategy for preventing antimicrobial resistance, informed by its implementation in a large Danish healthcare region comprising six public hospitals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Microbiology, Region Zealand, Zealand University Hospital-Koege, Koege, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Odense University Hospital, Odense, Denmark.
ORCID-Profile: Michael Kemp, Laus Krems Vejrum, Asta Lili Laugesen, Anne Line Engsbro
Förderung
- Region Zealand
- The Vissing Foundation
- The A.P. Moller Foundation for the Advancement of Medical Science
- Region Sjælland
- Vissing Fonden
Zitieren
APA
Kemp, M., Vejrum, L. K., Møller, J. T., Laugesen, A. L., Clausen, M. E., & Engsbro, A. L. (2026). A Strategy Against Antibiotic‐Resistant Bacteria: Optimizing Prevention of Transmission. APMIS, 134(11). https://doi.org/10.1111/apm.70273
Vancouver
Kemp M, Vejrum LK, Møller JT, Laugesen AL, Clausen ME, Engsbro AL. A Strategy Against Antibiotic‐Resistant Bacteria: Optimizing Prevention of Transmission. APMIS. 2026;134(11). doi:10.1111/apm.70273
BibTeX
@article{Kemp2026,
author = {Kemp, Michael and Vejrum, Laus Krems and Møller, Josefine Tange and Laugesen, Asta Lili and Clausen, Marianne Engell and Engsbro, Anne Line},
title = {A Strategy Against Antibiotic‐Resistant Bacteria: Optimizing Prevention of Transmission},
journal = {APMIS},
year = {2026},
volume = {134},
number = {11},
doi = {10.1111/apm.70273}
}
EUVIMED